Taysha Gene Therapies Stock News & Updates
[WKN: A2QCJL | Symbol: TSHA]
NEO-DARVAS STRATEGY: CECO Environmental, Taysha Gene Therapies, CommScope Holdings, Vicor Corporation
The NEO-DARVAS STRATEGY is a remarkable trend-following approach based on a simple yet powerful concept:...
Taysha Gene Therapies (TSHA): BofA Sees 214% Price Potential - TSHA-102 Could Achieve Risk-Adjusted Peak Revenue of $995 Million by 2031!
On May 28, Taysha Gene Therapies (TSHA) reported that it has made significant progress in the development...
Analysts' Top 5 Price Targets of July 11, 2025
LifeMD [US53216B1044] Lake Street reaffirms Buy rating and raises the price target from $12 to $18...
Taysha Gene Therapies (TSHA): Cantor Fitzgerald Sees an Increased Likelihood of Success for TSHA-102 - Stock Offers 387% Upside Potential
Taysha Gene Therapies (TSHA) reported on May 28 that significant progress has been made in the development...
Analysts' Top 5 Price Targets of May 30, 2025
Stratec SE [DE000STRA555]: Warburg Research maintains its rating at Buy and raises its price target from...
Taysha Gene Therapies Advances the Development of TSHA-102 for Rett Syndrome - Analysts see up to 133% Price Potential
On May 28, Taysha Gene Therapies (TSHA) reported significant progress in the development of TSHA-102,...
- ‹
- 1
- ›